LY3298176, a Novel Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus: From Discovery to Clinical Proof of Concept
Have a body composition measurement prior to starting these medications for a baseline
I recommend Reducore to people who: Have diabetes Are obese Want milder metabolic support Are not candidates for GLP-1 medications Do not want injections Want to support blood sugar balance naturally Are focused on gut health and satiety Want muscle-supportive metabolic nutrition Want to save money Want sustained weight loss over time without rebound weight gain My clients with Metabolic Syndrome Have high tryglycerides Have high blood pressure in conjunction with obesity It may also make sense for: People transitioning off GLP-1 medications Individuals trying to support maintenance habits People wanting nutirtional support alongside lifestyle changes What are the downsides to GLP-1 injections
This article explores evolving recommendations, highlights key uncertainties, and offers practical guidance for safer perioperative care
As we age, our levels of glutathione tend to decline
The Precision Peptide Genetic Test identifies predispositions in GLP-1 pathway genes (GIPR, FTO, MC4R), which may provide context for provider conversations but do not predict exact medication response or guarantee outcomes